Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer: An open-label phase II trial (VinMetAtezo)
Article in Lung Cancer (February 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Lung Cancer (February 2023)
Article in BMC Medicine (April 2022)